Pfizer’s Braftovi (encorafenib) regimen has been granted accelerated approval by the US Food and Drug Administration (FDA) to ...

As the world’s third largest pharmaceutical market, Japan accounted for approximately 6% of the $1.5tn in global ...

AstraZeneca’s Tagrisso (osimertinib) has been approved by the European Commission (EC) to treat a new subset of lung cancer ...

As a result, there does seem to be more attention on the patient across med affairs, marketing and communications activity.

If you are struggling to navigate the complexity of early commercialisation, rest assured, you are not alone. Clinical trial ...

Elevate your MedEd strategy with our 2025 toolkit! From AI-driven patient avatars to interactive augmented reality scenarios, ...

Is your medical education strategy reaching the right HCPs in the formats they prefer? Discover actionable insights to ...

Caregivers often play an integral role during interactions with medical professionals ...

Novo Nordisk has announced an investment of 8.5 billion Danish kroner, or approximately $1.2bn, to establish a new rare ...

Gilead Sciences’ seladelpar has been recommended by the European Medicines Agency’s human medicines committee to treat the ...